Showing results (951-960 of 1,002) with videos related to

Sort By:
Pageof 101
Blood|March 24, 2017
Reticular dysgenesis: international survey on clinical presentation, transplantation, and outcomeManfred Hoenig, Chantal Lagresle-Peyrou, Ulrich Pannicke, et al.
The New England Journal of Medicine|April 18, 2019
Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1Ewelina Mamcarz, Sheng Zhou, Timothy Lockey, et al.
The New England Journal of Medicine|December 9, 2024
Daratumumab or Active Monitoring for High-Risk Smoldering Multiple MyelomaMeletios A Dimopoulos, Peter M Voorhees, Fredrik Schjesvold, et al.
The Journal of Allergy and Clinical Immunology|August 20, 2022
Aberrant T-cell exhaustion in severe combined immunodeficiency survivors with poor T-cell reconstitution after transplantationRoxane Labrosse, Ines Boufaied, Benoîte Bourdin, et al.
Scientific Reports|October 17, 2020
Seven decades of chemotherapy clinical trials: a pan-cancer social network analysisXuanyi Li, Elizabeth A Sigworth, Adrianne H Wu, et al.
The Lancet. Haematology|October 18, 2016
Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysisImke H Bartelink, Arief Lalmohamed, Elisabeth M L van Reij, et al.
Transplantation and Cellular Therapy|December 9, 2022
Stem Cell Mobilization Yields with Daratumumab- and Lenalidomide-Containing Quadruplet Induction Therapy in Newly Diagnosed Multiple Myeloma: Findings from the MASTER and GRIFFIN TrialsSaurabh Chhabra, Natalie Callander, Nicole L Watts, et al.
Blood Cancer Journal|April 22, 2024
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic riskNatalie S Callander, Rebecca Silbermann, Jonathan L Kaufman, et al.
Blood|October 24, 2022
Hypomorphic RAG deficiency: impact of disease burden on survival and thymic recovery argues for early diagnosis and HSCTC Schuetz, J Gerke, M Ege, et al.
Blood|October 13, 2017
Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history studyJennifer Heimall, Brent R Logan, Morton J Cowan, et al.
Pageof 101